Targeted Alpha Therapy (TAT) has emerged as one of the most powerful cancer treatment available thanks to its ability to cause large amounts of damage near a tumor cell while keeping the healthy surrounding tissue intact.
NIDC News
The U.S. Department of Energy’s (DOE) Office of Science is pleased to announce that the Office of Science Graduate Student Research (SCGSR) program is now accepting applications for the 2025 solicitation 1 cycle.
The U.S. Department of Energy’s Office of Science, under the Isotope R&D and Production (DOE IP) Program, is issuing an $11 million funding opportunity announcement.
The DOE IP is currently seeking researchers to evaluate Sb-119 samples from a recent test batch and future batches. This material will be provided free of charge, except shipping fees, in exchange for technical and other relevant feedback.
DOE Isotope Program Highlights
Automated Nuclear Chemistry Boosts Astatine Production for Cancer Therapy
A team of researchers designed and tested an automated protocol aimed at reducing the At-211 processing procedure from dissolution of the irradiated target through column purification in just 20 minutes.
Spherical Powders Enable New Applications for Metals
Free-flowing metal powders offer improvements for additive manufacturing, isotope production target fabrication, and more.
New Understanding of Astatine’s Chemical Properties Will Aid Targeted Alpha Therapy for Cancer
Recently, scientists at Texas A&M University investigated astatine’s behavior when interacting with ion exchange and extraction chromatography resins.
